Bristol to Sell 80% Off Psoriasis Pill After Trump Demand

BLOOMBERG

Bristol Myers Squibb Co. will sell its pill for psoriasis directly to cash-paying patients at a more than 80% discount to the drug’s list price, following President Donald Trump’s demand that pharmaceutical companies slash the costs of their medicines in the US.

Beginning in January, patients will be able to buy Sotyktu directly through an online platform called BMS Patient Connect, Bristol said Thursday. The drug, approved to treat moderate to severe plaque psoriasis, has a list price of about $6,800 for a 30-day supply. The company said it will look to eventually sell more of its medicines directly to patients through the website.

“We are taking a leading role in removing barriers, providing transparency and lowering out-of-pocket costs so patients in the United States can get the treatments they need — delivered directly to their door, wherever they are in the country,” Bristol Chief Executive Officer Christopher Boerner said in a statement.

Read more here.